Soluble CD4 and CD8 in serum from patients with localized scleroderma

Archives of Dermatological Research

Volumn 288, Issue 7, 1996, Pages 358-362

  Sato, Shinichi ^a   Fujimoto, Manabu ^a   Kikuchi, Kanako ^b   Ihn, Hironobu ^a   Tamaki, Kunihiko ^a   Takehara, Kazuhiko ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

CD4; CD8; Localized scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; CD23 ANTIGEN; CD8 ANTIGEN; HISTONE ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; RHEUMATOID FACTOR; SINGLE STRANDED DNA; SOLUBLE CD4 ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MORPHEA; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

ADULT; ANTIBODIES; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD4; ANTIGENS, CD8; DNA, SINGLE-STRANDED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTONES; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; SCLERODERMA, LOCALIZED; SOLUBILITY;

EID: 0030055562     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050063     Document Type: Article

References (33)

1. Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y (1983) Antinuclear antibodies in localized scleroderma. Arthritis Rheum 26:612-616
2. Ruffatti A, Peserico A, Glorioso S, Fiocco U, Rossi L, Gambari P, Todesco S (1986) Anticentromere antibody in localized scleroderma. J Am Acad Dermatol 15:637-642
3. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP (1986) Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med 104:849-857
4. Falanga V, Medsger TA Jr, Reichlin M (1987) Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123:350-353
5. Kikuchi K, Takehara K, Ishibashi Y (1989) Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads. J Am Acad Dermatol 21:1301-1303
6. Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K (1993) Antihistone antibodies in patients with localized scleroderma. Arthritis Rheum 36:1137-1141
7. Scarola JA, Shulman LE (1975) Serologic abnormalities and their significance in localized scleroderma (abstract). Arthritis Rheum 18:526
8. Falanga V, Medsger TA Jr, Reichlin M (1985) High titers of antibodies to single-stranded DNA in linear scleroderma. Arch Dermatol 121:345-347
9. Takehara K, Kikuchi K, Soma Y, Igarashi A, Ishibashi Y (1990) Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma. Arch Dermatol 126:1368-1369
10. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Antigen specificity of antihistone antibodies in localized scleroderma. Arch Dermatol 130:1273-1277
11. Sato S, Fujimoto M, Kikuchi K, Ihn H, Takehara K (1996) Elevated soluble CD23 levels in the sera from patients with localized scleroderma. Arch Dermatol Res 288 (in press)
12. Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K (1995) Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 287:193-197
13. Uziel Y, Krafchik BR, Feldman B, Silverman ED, Rubin LA, Laxer RM (1994) Serum levels of soluble interleukin-2 receptor: a marker of disease activity in localized scleroderma. Arthritis Rheum 37:898-901
14. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K (1994) Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 31: 1273-1277
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1986) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 26:612-616
16. LeRoy EC, Krieg T, Black C, Medsger TA Jr, Fleischmajer R, Rowell N, Jablonska, S, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
17. Sato S, Ihn H, Kikuchi K, Takehara K (1994) Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum 37:391-394
18. Fujimoto J, Levy S, Levy R (1983) Spontaneous release of the Leu-2 (T8) molecule from human T cells. J Exp Med 159:752-756
19. Fujimoto J, Stewart S, Levy R (1984) Immunochemical analysis of the released Leu-2 (T8) molecules. J Exp Med 160:116-124
20. Giblin P, Ledbetter JA, Kavathas P (1989) A secreted form of the human lymphocyte cell surface molecule CD8 arises from alternative splicing. Proc Natl Acad Sci USA 86:998-1002
21. Tomkinson BE, Brown MC, Ip SH, Carrahis S, Sullivan JL (1989) Soluble CD8 during T cell activation. J Immunol 142: 2230-2236
22. Sawada S, Sugai S, Iijima S, Takei M, Paredes E, Hayama T, Nishinavita S, Hosokawa Y, Horie T, Obara T (1992) Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjøgren's syndrome. Am J Med 92:134-140
23. Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabata K (1991) Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 86:134-139
24. Lipnick RN, Sfikakis PP, Klipple GL, Tsokos GC (1993) Elevated soluble CDS antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis. Clin Immunol Immunopathol 68:64-67
25. Symons JA, Wood NC, Di Giovine FS, Duff GW (1990) Soluble CD8 in patients with rheumatic diseases. Clin Exp Immunol 80:354-359
26. Famularo G, Giacomelli R, Sacchetti S, Danese C, Luciani AM, Perego MA, Tonietti G (1990) Soluble CD8 antigen in systemic sclerosis. J Clin Lab Immunol 32:109-112
27. Tokano Y, Kaneko H, Obara T. Hashimoto H, Okumura K, Hirose S (1993) Soluble CD4 and CD8 molecules in patients with systemic sclerosis. Clin Rheumatol 12:490-493
28. Kahaleh MB (1991) Soluble immunologic products in scleroderma sera. Clin Immunol Immunopathol 58:139-144
29. Reinherz EL, Kung PC, Goldstein G, Schlossman SF (1979) Separation of functional subsets of human T cells by a monoclonal antibody. Proc Natl Acad Sci USA 76:4061-4065
30. Deen KC, McDougal JS, Inacker R, Folena-Wasserman G, Arthos J, Rosenberg J, Maddon PJ, Axel R, Sweet RW (1988) A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature 331:82-84
31. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janis J, Vergani D (1991) Activation of T lymphocytes in Dengue virus infections. J Clin Invest 88:1473-1480
32. Peakman M, Senaldi G, Foote N, McManus TJ, Vergani D (1992) Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection. J Infect Dis 165:799-804
33. Symons JA, McCulloch JF, Wood NC, Duff GW (1991) Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol 60:72-82